Top 5 Medical Stocks To Buy Right Now

Boston, MA, based Investment company North Tide Capital, Llc buys Impax Laboratories, Allergan PLC, Accuray, sells Community Health Systems, Valeant Pharmaceuticals International, Mylan NV, Perrigo Co PLC, Select Medical Holdings during the 3-months ended 2016-12-31, according to the most recent filings of the investment company, North Tide Capital, Llc. As of 2016-12-31, North Tide Capital, Llc owns 14 stocks with a total value of $483 million. These are the details of the buys and sells.

New Purchases: IPXL, AGN, ARAY, Added Positions: MYGN, KND, Reduced Positions: MYL, SEM, SVU, GILD, LPNT, Sold Out: CYH, VRX, PRGO, AFAM, ADUS,

For the details of NORTH TIDE CAPITAL, LLC’s stock buys and sells, go to

These are the top 5 holdings of NORTH TIDE CAPITAL, LLCSelect Medical Holdings Corp (SEM) – 10,000,000 shares, 27.46% of the total portfolio. Shares reduced by 23.66%SUPERVALU Inc (SVU) – 18,469,921 shares, 17.87% of the total portfolio. Shares reduced by 24.61%Gilead Sciences Inc (GILD) – 500,000 shares, 7.42% of the total portfolio. Shares reduced by 37.5%Kindred Healthcare Inc (KND) – 4,250,000 shares, 6.91% of the total portfolio. Shares added by 6.25%Syneron Medical Ltd (ELOS) – 3,500,000 shares, 6.09% of the total portfolio. New Purchase: Impax Laboratories Inc (IPXL)

North Tide Capital, Llc initiated holdings in Impax Laboratories Inc. The purchase prices were between $12.75 and $24.23, with an estimated average price of $17.1. The stock is now traded at around $9.35. The impact to the portfolio due to this purchase was 5.49%. The holdings were 2,000,000 shares as of 2016-12-31.

Top 5 Medical Stocks To Buy Right Now: Dunkin' Brands Group, Inc.(DNKN)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Keurigs plight (actually, JABs) is worsening, with the K-cup market slowing to almost no growth now, and Keurig continuing to lose own brands share. Starbucks (SBUX) echoed the notion of a K-cup market slowdown at its seminar on Wednesday (and is guiding for its [consumer packaged goods, or CPG,] growth below recent trends), but it expects to increase its share of total CPG coffee to 20% from 15%. Come early February it will be a year since the closing of the Keurig deal for JAB Holdings. The pressure on JAB is more significant if we take into account the high leverage of the deal (JAB contributed one fourth of the $12Bn price tag). It is a tough predicament. On the one hand we argue that to make that deal work, they need to buy more (own) brands either from the retail channel (that can be extended to CPG: Dunkin (DNKN)? Panera (PNRA)?), or outright buy CPG brands (like the entire Kraft Heinz portfolio, and or Tata Groups Eight OClock brand). But can/how do they fund these deals? Maybe Mars and Warren Buffett (Mars is involved in office coffee with Starbucks), private equity, and or 3G can help? While this note is not about Positive-rated Mondelez, we have mentioned before a scenario where Kraft Heinz buys Mondelez and partly funds the deal by selling its own CPG coffee business (~$3Bn we say) to JAB as well as divests the Mondelez 20% plus stakes in Keurig (North America) and Jacobs Douwe Egberts (Western Europe), which together at this stage are worth ~$7-8Bn. But, yes, JAB will need deep-pocket partners and generous lenders. Net, JAB needs to do something soon.

  • [By Ben Levisohn]

    The market is treating Chipotle as if it is an Amazon, Tesla, Apple or Google, when in fact all they do is make burritos. With the money it would cost you to buy Chipotle today @ $14 billion dollars you could buy Wendy’s (WEN), Cheesecake Factory (CAKE), Papa John’s International (PZZA), and Dunkin’ Brands (DNKN). Chipotle would need to generate at least $24 in earnings per share in order to justify the current market cap — they are not even expected to generate half of that next year. Chipotle is expected to report Q1 on April 25 and the market, in my opinion, has already more than priced in good news.

  • [By Asit Sharma]

    Dunkin’ Brands Group, Inc. (NASDAQ:DNKN) is currently testing a concept in 300 U.S. stores that may surprise many of its investors: a streamlined menu.

  • [By Ben Levisohn]

    Dunkin’ Brands Group (DNKN) has dropped 3.5% to $54.16 after getting cut to Sell from Neutral at Goldman Sachs.

    Morgan Stanley (MS) has risen 1.1% to $42.95 after getting upgraded to Buy from Hold at Deutsche Bank.

  • [By John Udovich]

    While theMacys Thanksgiving Day parade sponsored by Macy’s, Inc (NYSE:M) is the most well known corporate sponsoredThanksgiving parade,Dunkin Brands Group Inc (NASDAQ:DNKN) and McDonald’s Corporation (NYSE:MCD) also sponsor parades in major USA cities that will help them grab some extra consumer attention and perhaps help the bottom line a bit.

Top 5 Medical Stocks To Buy Right Now: ADDvantage Technologies Group, Inc.(AEY)

Advisors’ Opinion:

  • [By Jim Robertson]

    Today, our Under the Radar Moversnewsletter suggestedshorting small cap cable television and telecommunications equipment stock ADDvantage Technologies Group, Inc (NASDAQ: AEY):

Top 5 Medical Stocks To Buy Right Now: The Bon-Ton Stores, Inc.(BONT)

Advisors’ Opinion:

  • [By Peter Graham]

    The Q4 2016 earnings report for small cap department store stock The Bon-Ton Stores, Inc (NASDAQ: BONT)is scheduled for before the market opens on Tuesday (March 14th). In January, The Bon-Ton Stores announced that its comparable store sales for the nine-week holiday period ended December 31, 2016 had decreased 3.1% -in line with guidance. The CEO commented:

  • [By Peter Graham]

    Small cap department store stock The Bon-Ton Stores, Inc (NASDAQ: BONT)reported fiscalQ1 earnings before the market opened this morning with total salesdown 9.3% to $536.1 million and comparable store sales down 8.8%. Theearnings release noted:

  • [By Peter Graham]

    Small cap department store stock The Bon-Ton Stores, Inc (NASDAQ: BONT) reported Q2 2017 earnings before the market opened on Thursday while earnings guidance for the full year fiscal 2017 was reaffirmed. Total sales decreased 7.0% to $504.4 million as comparable store sales decreased 6.1% versus the prior year period. However,double-digit sales growth continued in the omnichannel, which reflects sales via the Company’s website, mobile site, and its Let Us Find It customer service program, as the Company leveraged its West Jefferson facility and store-fulfillment network. The net loss was $33.2 million versus a net loss of $38.7 million.The CEO commented:

  • [By Adam Levine-Weinberg]

    Not long ago, liquidation seemed inevitable for bankrupt department store operator Bon-Ton Stores Inc. (NASDAQ:BONT). The company’s desperate attempt to restructure outside the bankruptcy process failed earlier this year when it couldn’t find an investor willing to finance a comeback effort.

  • [By Paul Ausick]

    The Bon-Ton Stores Inc. (NASDAQ: BONT) dropped about 3.3% Thursday to post a new 52-week low of $0.31 after closing Wednesday at $0.32. The 52-week high is $1.98. Volume was around 10 million shares traded, about 100 times the daily average of around 100,000. The struggling retailer had no specific news.

Top 5 Medical Stocks To Buy Right Now: Midatech Pharma PLC(MTP)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    But before we show you our pick, here are the top 10 penny stocks to watch this week…

    Penny Stocks Current Share Price (as of Jan. 5) Jan. 2-5 Gain (as of Jan. 5)
    My Size Inc. (Nasdaq: MYSZ) $1.66 152.28%
    Cytori Therapeutics Inc. (Nasdaq: CYTX) $0.47 89.52%
    DelMar Pharmaceuticals Inc. (Nasdaq: DMPI) $1.675 58.02%
    CAS Medical Systems Inc. (Nasdaq: CASM) $1.09 55.71%
    China HGS Real Estate Inc. (Nasdaq: HGSH) $1.83 47.58%
    Aethlon Medical Inc. (Nasdaq: AEMD) $1.56 43.12%
    Midatech Pharma Plc. (Nasdaq: MTP) $1.23 43.01%
    Comstock Holding Cos. Inc. (Nasdaq: CHCI) $1.87 36.5%
    Cenveo Inc. (Nasdaq: CVO) $1.20 31.82%
    EV Energy Partners LP (Nasdaq: EVEP) $0.6844 31.62%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, it’s completely free…

Top 5 Medical Stocks To Buy Right Now: Citigroup Inc.(C)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    The price of Bitcoin faced more pressure over the weekend. The downturn came on news that several major banks have banned the purchasing of Bitcoin with credit cards. Bank of America Corp. (NYSE: BAC), JPMorgan Chase & Co. (NYSE: JPM), and Citigroup Inc. (NYSE: C) have all banned cryptocurrency purchases since Friday. This means that the top five credit card issuers have now halted the practice. Bitcoin sat at $7,773 this morning.
    Janet Yellen is officially out of the Federal Reserve and will be heading to the Brookings Institution. Today, Jerome Powell will begin his first term at the helm of the U.S. central bank. Powell takes over at an interesting time for the U.S. economy. The central bank is expected to raise interest rates three times in 2017. In addition, Powell must manage a $4.5 trillion balance sheet that the Fed built up in the wake of last decade’s financial crisis.
    Gold prices saw a slight gain in pre-market hours. But those gains could surge as markets continue to face questions about inflation and a weaker U.S. dollar. Gold prices saw one of their biggest one-day declines in two months on Friday. Investors are looking at this as a solid entry point given price expectations from Money Morning Resource Specialist Peter Krauth. Peter expects that gold prices will reach $1,400 by the end of June and rise to as high as $1,500 by December.
    VideoMeet the Trading Expert Who Could Help Make You a Millionaire
    Crude oil prices slid in pre-market hours to a one-month low. TheWTI crude oil price todayfell 0.6%. Brent crude dropped 1.1%. Markets are growing increasingly fearful that rising U.S. production could spur an oversupply of the markets.
    Four Stocks to Watch Today: WFC, AVGO, QCOM, BMY
    Shares of Wells Fargo & Co. (NYSE: WFC) are off more than 8% this morning because the Fed has forced new sanctions on the bank that will limit its growth. The Fed’s consent order will see the bank change four members of its board of directors and

  • [By ]

    Everything is hot, always: (1) Well-known bank analyst Mike Mayo told TheStreet’s Scott Gamm that former Goldman exec (and Trump exec) Gary Cohn would be a good person to replace Citigroup’s (C) chairman; (2) TheStreet’s May 5 “Investing Bootcamp” conference in New York is a MUST attend — here is just a small sampling of what we will be discussing; (3) TheStreet’s new “Retirement Daily’ service is now live. Led by long-time retirement expert, aka “Mr. Retirement” Robert Powell, this is an amazing service. Trust me, I get to view all the content before it goes live … there is nothing else like it out there. Check out more here; (4) RealMoney Pro’s long-time columnist and money manager Doug Kass hops out briefly from behind the paywall with a new daily column called Kass Insider. First installment: Why Facebook’s Stock Could Be ‘Dead Money’ for the Rest of 2018.

  • [By Chris Lange]

    Citigroup Inc. (NYSE: C) short interest increased slightly to 27.66 million from the previous level of 27.35 million. Shares were trading at $75.05, in a 52-week range of $56.55 to $80.70.

  • [By Chris Lange]

    The Citigroup Inc. (NYSE: C) fourth-quarter report is scheduled for Friday. The consensus forecast is $1.61 in EPS on $18.8 billion in revenue. Shares closed at $68.60 apiece. The consensus price target is $83.41, and the 52-week range is $56.55 to $80.70.

  • [By Chris Lange]

    The latest quarterly earnings from Citigroup Inc. (NYSE: C) are due onWednesday. The fourth-quarter consensus forecast calls for $1.12 in EPS and $17.3 billion in revenue. Shares were trading at $59.63 on Fridays close, in a 52-week range of $34.52 to $61.63. The consensus price target is $64.31.